Polyunsaturated fatty acid and S-adenosylmethionine supplementation in predementia syndromes and Alzheimer's disease: A review

TheScientificWorldJournal

Volumn 9, Issue , 2009, Pages 373-389

  Panza, Francesco ^a   Frisardi, Vincenza ^a   Capurso, Cristiano ^b   D'Introno, Alessia ^a   Colacicco, Anna M ^a   Di Palo, Alessandra ^a   Imbimbo, Bruno P ^c   Vendemiale, Gianluigi ^b,d   Capurso, Antonio ^a   Solfrizzi, Vincenzo ^a  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF FOGGIA   (Italy)

^c Research and Development Department   (Italy)

^d IRCSS Casa Sollievo Dalla Sofferenza   (Italy)

Author keywords

Alzheimer's disease; Mild cognitive impairment; n 3 polyunsaturated fatty acids; S adenosylhomocysteine; S adenosylmethionine

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; ALZHEIMER DISEASE VACCINE; AMYLOID BETA PROTEIN; ARACHIDONIC ACID; CYANOCOBALAMIN; DOCOSAHEXAENOIC ACID; FISH OIL; FOLIC ACID; GLUTATHIONE TRANSFERASE; HOMOCYSTEINE; ICOSAPENTAENOIC ACID; LEVACECARNINE; NUTRACEUTICAL; OLIVE OIL; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PYRIDOXINE; S ADENOSYLHOMOCYSTEINE; S ADENOSYLMETHIONINE; UNSATURATED FATTY ACID;

ALZHEIMER DISEASE; DIET SUPPLEMENTATION; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; DRUG TOLERABILITY; ENZYME ACTIVITY; FOLLOW UP; HUMAN; MILD COGNITIVE IMPAIRMENT; MULTIINFARCT DEMENTIA; NEUROBIOLOGY; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; REVIEW; SINGLE DRUG DOSE; TREATMENT DURATION; ANIMAL; CLINICAL TRIAL; DEMENTIA; DISEASE MODEL; PATHOLOGY; TREATMENT OUTCOME;

ALZHEIMER DISEASE; ANIMALS; CLINICAL TRIALS AS TOPIC; DEMENTIA; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; FATTY ACIDS, UNSATURATED; HUMANS; S-ADENOSYLMETHIONINE; TREATMENT OUTCOME;

EID: 66849127876     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/tsw.2009.48     Document Type: Review

References (126)

1. Fratiglioni, L. and Qiu, C. (2008) Prevention of common neurodegenerative disorders in the elderly. Exp. Gerontol. 44(1-2), 46-50.
2. Qiu, C., De Ronchi, D., and Fratiglioni, L. (2007) The epidemiology of the dementias: an update. Curr. Opin. Psychiatry 20, 380-385.
3. Whitehouse, P.J., Sciulli, C.G., and Mason, R.M. (1997) Dementia drug development: use of information systems to harmonize global drug development. Psychopharmacol. Bull. 33, 129-133. (Pubitemid 27184207)
4. Panza, F., D'Introno, A., Colacicco, A.M., Capurso, C., Del Parigi, A., Caselli, R.J., Pilotto, A., Argentieri, G., Scapicchio, P.L., Scafato, E., Capurso, A., and Solfrizzi, V. (2005) Current epidemiology of mild cognitive impairment and other predementia syndromes. Am. J. Geriatr. Psychiatry 13, 633-644. (Pubitemid 41197234)
5. Panza, F., D'Introno, A., Colacicco, A.M., Capurso, C., Del Parigi, A., Capurso, S.A., Caselli, R.J., Pilotto, A., Scafato, E., Capurso, A., and Solfrizzi, V. (2006) Cognitive frailty: predementia syndrome and vascular risk factors. Neurobiol. Aging 27, 933-940. (Pubitemid 43732521)
6. Panza, F., Solfrizzi, V., Frisardi, V., Capurso, C., D'Introno, A,, Colacicco, A.M., Vendemiale, G., Capurso, A., and Imbimbo, B.P. (2009) Disease-modifying approach for the treatment of Alzheimer's disease: from α-secretase activators to γ-secretase inhibitors and modulators. Drugs Aging, in press.
7. Alzheimer, A. (1907) Uber eine eigenartige Erkrankung der Hirnrinde. Allg. Z. Psychiatr. 64, 146-148.
8. Terry, R.D. (2006) Alzheimer's disease at mid century (1927-1977). In Alzheimer: 100 Years and Beyond. Jucker, M., Beyreuther, K., Haas, C., and Nitsch, R., Eds. Springer-Verlag, Berlin. pp. 58-61.
9. Giacobini, E. and Becker, R.E. (2007) One hundred years after the discovery of Alzheimer's disease. A turning point for therapy? J. Alzheimers Dis. 12, 37-52. (Pubitemid 47396306)
10. Walter, J., Kaether, C., Steiner, H., and Haass, C. (2001) The cell biology of Alzheimer's disease: uncovering the secrets of secretases. Curr. Opin. Neurobiol. 11, 585-590. (Pubitemid 32938290)
11. Ohyagi, Y., Asahara, H., Chui, D.H., Tsuruta, Y., Sakae, N., Miyoshi, K., Yamada, T., Kikuchi, H., Taniwaki, T., Murai, H., Ikezoe, K., Furuya, H., Kawarabayashi, T., Shoji, M., Checler, F., Iwaki, T., Makifuchi, T., Takeda, K., Kira, J., and Tabira, T. (2005) Intracellular Abeta42 activates p53 promoter: a pathway to neurodegeneration in Alzheimer's disease. FASEB J. 19, 255-257.
12. Hardy, J. and Allsop, D. (1991) Amyloid deposition as the central event in the aetiology of Alzheimer's disease. Trends Pharmacol. Sci. 12, 383-388.
13. Hardy, J. and Selkoe, D.J. (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353-356. (Pubitemid 34790756)
14. Castellani, R.J., Lee, H.G., Zhu, X., Perry, G., and Smith, M.A. (2008) Alzheimer disease pathology as a host response. J. Neuropathol. Exp. Neurol. 67, 523-531. (Pubitemid 351787079)
15. Crystal, H.A., Dickson, D.W., Sliwinski, M.J., Lipton, R.B., Grober, E., Marks-Nelson, H., and Antis, P. (1993) Pathological markers associated with normal aging and dementia in the elderly. Ann. Neurol. 34, 566-573. (Pubitemid 23289408)
16. Knopman, D.S., Parisi, J.E., Salviati, A., Floriach-Robert, M., Boeve, B.F., Ivnik, R.J., Smith, G.E., Dickson, D.W., Johnson, K.A., Petersen, L.E., McDonald, W.C., Braak, H., and Petersen, R.C. (2003) Neuropathology of cognitively normal elderly. J. Neuropathol. Exp. Neurol. 62, 1087-1095.
17. Holmes, C., Boche, D., Wilkinson, D., Yadegarfar, G., Hopkins, V., Bayer, A., Jones, R.W., Bullock, R., Love, S., Neal, J.W., Zotova, E., and Nicoll, J.A. (2008) Long-term effects of Aβ42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial. Lancet 372, 216-223. (Pubitemid 351978111)
18. Puzzo, D., Privitera, L., Leznik, E., Fà, M., Staniszewski, A., Palmeri, A., and Arancio, O. (2008) Picomolar amyloid-β positively modulates synaptic plasticity and memory in hippocampus. J. Neurosci. 28, 14537-14545.
19. Chen, Y. and Dong, C. (2009) Aβ40 promotes neuronal cell fate in neural progenitor cells. Cell Death Differ. 16, 386-394.
20. Lee, H.G., Zhu, X., Nunomura, A., Perry, G., and Smith, M.A. (2006) Amyloid beta: the alternate hypothesis. Curr. Alzheimer Res. 3, 75-80.
21. Hayashi, T., Shishido, N., Nakayama, K., Nunomura, A., Smith, M.A, Perry, G., and Nakamura, M. (2007) Lipid peroxidation and 4-hydroxy-2-nonenal formation by copper ion bound to amyloid-beta peptide. Free Radic. Biol. Med. 43, 1552-1559. (Pubitemid 47615399)
22. Nakamura, M., Shishido, N., Nunomura, A., Smith, M.A., Perry, G., Hayashi, Y., Nakayama, K., and Hayashi, T. (2007) Three histidine residues of amyloid-beta peptide control the redox activity of copper and iron. Biochemistry 46, 12737-12743. (Pubitemid 350064223)
23. Bryan, J., Calvaresi, E., and Hughes, D. (2002) Short-term folate, vitamin B-12 or vitamin B-6 supplementation slightly affects memory performance but not mood in women of various ages. J. Nutr. 132, 1345-1356. (Pubitemid 34606475)
24. Luchsinger, J.A., Tang, M.X., Shea, S., and Mayeux, R. (2003) Antioxidant vitamin and risk of Alzheimer disease. Arch. Neurol. 60, 203-208. (Pubitemid 36193963)
25. Salerno-Kennedy, R. and Cashman, K.D. (2005) Relationship between dementia and nutrition-related factors and disorders: an overview. Int. J. Vitam. Nutr. Res. 75, 83-95. (Pubitemid 40637736)
26. Balk, E.M., Raman, G., Tatsioni, A., Chung, M., Lau, J., and Rosenberg, I.H. (2007) Vitamin B6, B12, and folic acid supplementation and cognitive function: a systematic review of randomized trials. Arch. Intern. Med. 167, 21-30. (Pubitemid 46072403)
27. Malouf, R. and Grimley Evans, J. (2008) Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people. Cochrane Database Syst. Rev. CD004514.
28. Aisen, P.S., Schneider, L.S., Sano, M., Diaz-Arrastia, R., van Dyck, C.H., Weiner, M.F., Bottiglieri, T., Jin, S., Stokes, K.T., Thomas, R.G., Thal, L.J.; Alzheimer Disease Cooperative Study (2008) High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial. JAMA 300, 1774-1783.
29. Masaki, K.H., Losonczy, K.G., Izmirlian, G., Foley, D.J., Ross, G.W., Petrovitch, H., Havlik, R., and White, L.R. (2000) Association of vitamin E and C supplement use with cognitive function and dementia in elderly men. Neurology 54, 1265-1272. (Pubitemid 30174045)
30. Solfrizzi, V., Capurso, C., D'Introno, A., Colacicco, A.M., Frisardi, V., Santamato, A., Ranieri, M., Fiore, P., Vendemiale, G., Seripa, D., Pilotto, A., Capurso, A., and Panza, F. (2008) Dietary fatty acids, age-related cognitive decline, and mild cognitive impairment. J. Nutr. Health Aging 12, 382-386. (Pubitemid 351957300)
31. van de Rest, O., Geleijnse, J.M., Kok, F.J., van Staveren, W.A., Hoefnagels, W.H., Beekman, A.T., and de Groot, L.C. (2008) Effect of fish-oil supplementation on mental well-being in older subjects: a randomized, double-blind, placebo-controlled trial. Am. J. Clin. Nutr. 88, 706-713.
32. Petersen, R.C., Thomas, R.G., Grundman, M., Bennett, D., Doody, R., Ferris, S., Galasko, D., Jin, S., Kaye, J., Levey, A., Pfeiffer, E., Sano, M., van Dyck, C.H., Thal, L.J.; Alzheimer's Disease Cooperative Study Group (2005) Vitamin E and donepezil for the treatment of mild cognitive impairment. N. Engl. J. Med. 352, 2379-2388.
33. Tabet, N., Birks, J., and Grimley, E.J. (2000) Vitamin E for Alzheimer's disease. Cochrane Database Syst. Rev., CD002854.
34. Sano, M., Ernesto, C., Thomas, R.G., Klauber, M.R., Schafer, K., Grundman, M., Woodbury, P., Growdon, J., Cotman, C.W., Pfeiffer, E., Schneider, L.S., and Thal, L.J. (1997) A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. N. Engl. J. Med. 336, 1216-1222. (Pubitemid 27183651)
35. Sonnen, J.A., Larson, E.B., Gray, S.L., Wilson, A., Kohama, S.G., Crane, P.K., Breitner, J.C., and Montine, T.J. (2009) Free radical damage to cerebral cortex in Alzheimer's disease, microvascular brain injury, and smoking. Ann. Neurol. 65, 226-229.
36. Perry, G., Zhu, X., Moreira, P.I., and Smith, M.A. (2009) Altered redox balance in disease: can we change the new equilibria? Ann. Neurol. 65, 121-123.
37. Lloret, A., Badía, M.-C., Mora, N.J., Pallardó, F.V., Alonso, M.-D., and Viña J. (2009) Vitamin E paradox in Alzheimer's disease: it does not prevent loss of cognition and may even be detrimental. J. Alzheimers Dis., in press.
38. National Institute on Aging. Prevention of Alzheimer's Disease by VItamin E and SElenium (PREADVISE)[online]. Available from URL: http://www. clinicaltrials.gov [Accessed 30 November 2008].
39. Hajieva, P. and Behl, C. (2006) Antioxidants as a potential therapy against age-related neurodegenerative diseases: amyloid beta toxicity and Alzheimer's disease. Curr. Pharm. Des. 12, 699-704.
40. National Institute on Aging. Anti-oxidant treatment of Alzheimer's disease [online]. Available from URL: http://www.clinicaltrials.gov [Accessed 30 November 2008].
41. Panza, F., Solfrizzi, V., Colacicco, A.M., D'Introno, A., Capurso, C., Torres, F., Del Parigi, A., Capurso, S., and Capurso, A. (2004) Mediterranean diet and cognitive decline. Public Health Nutr. 7, 959-963.
42. Panza, F., Capurso, C., D'Introno, A., Colacicco, A.M., Chirico, M., Capurso, A., and Solfrizzi, V. (2007) Dietary polyunsaturated fatty acid supplementation, pre-dementia syndromes, and Alzheimer's disease. J. Am. Geriatr. Soc. 55, 469-470.
43. Solfrizzi, V., Colacicco, A.M., D'Introno, A., Capurso, C., Torres, F., Rizzo, C., Capurso, A., and Panza, F. (2006) Dietary intake of unsaturated fatty acids and age-related cognitive decline: a 8.5-year follow-up of the Italian Longitudinal Study on Aging. Neurobiol. Aging 27, 1694-1704. (Pubitemid 44363108)
44. Solfrizzi, V., Colacicco, A.M., D'Introno, A., Capurso, C., Del Parigi, A., Capurso, S.A., Argentieri, G., Capurso, A., and Panza, F. (2005) Dietary fatty acids intake: possible role in cognitive decline and dementia. Exp. Gerontol. 40, 257-270. (Pubitemid 40488193)
45. Woodside, J.V., McCall, D., McGartland, C., and Young, I.S. (2005) Micronutrients: dietary intake v. supplement use. Proc. Nutr. Soc. 64, 543-553. (Pubitemid 41705455)
46. Birks, J. and Grimley Evans, J. (2009) Ginkgo biloba for cognitive impairment and dementia. Cochrane Database Syst. Rev. CD003120.
47. Kleijnen, J. and Knipschild, P. (1992) Ginkgo biloba for cerebral insufficiency. Br. J. Clin. Pharmacol. 34, 352-358.
48. Huang, H.Y., Caballero, B., Chang, S., Alberg, A., Semba, R., Schneyer, C., Wilson, R.F., Cheng, T.Y., Prokopowicz, G., Barnes, G.J., 2nd, Vassy, J., and Bass E.B. (2006) Multivitamin/mineral supplements and prevention of chronic disease. Evid. Rep. Technol. Assess. (Full Rep), 1-117.
49. McDaniel, M.A., Maier, S.F., and Einstein, G.O. (2003) "Brain-specific" nutrients: a memory cure? Nutrition 19, 957-975.
50. Chan, A., Tchantchou, F., Graves, V., Rozen, R., and Shea, T.B. (2008) Dietary and genetic compromise in folate availability reduces acetylcholine, cognitive performance and increases aggression: critical role of S-adenosyl methionine. J. Nutr. Health Aging 12, 252-261. (Pubitemid 352025873)
51. Choi, J., Conrad, C.C., Dai, R., Malakowsky, C.A., Talent, J.M., Carroll, C.A., Weintraub, S.T., and Gracy, R.W. (2003) Vitamin E prevents oxidation of antiapoptotic proteins in neuronal cells. Proteomics 3, 73-77. (Pubitemid 36151070)
52. Rogers, E.J., Milhalik, S., Orthiz, D., and Shea, T.B. (2004) Apple juice prevents oxidative stress and impaired cognitive performance caused by genetic and dietary deficiencies in mice. J. Nutr. Health Aging 8, 92-97. (Pubitemid 38374595)
53. Tchantchou, F., Graves, M., Falcone, D., and Shea, T.B. (2008) S-adenosylmethionine mediates glutathione efficacy by increasing glutathione S-transferase activity: implications for S-adenosyl methionine as a neuroprotective dietary supplement. J. Alzheimers Dis. 14, 323-328. (Pubitemid 352040043)
54. Willis, L.M., Shukitt-Hale, B., and Joseph, J.A. (2009) Recent advances in berry supplementation and age-related cognitive decline. Curr. Opin. Clin. Nutr. Metab. Care 12, 91-94.
55. Berman, K. and Brodaty, H. (2004) Tocopherol (vitamin E) in Alzheimer's disease and other neurodegenerative disorders. CNS Drugs 18, 807-825. (Pubitemid 39410103)
56. Morris, M.C., Evans, D.A., Tangey, C.C., Bienas, J.L., Wilson, R.S., and Aggarwal, N.T. (2005) Relation of the tocopherol forms to incident Alzheimer's disease and to cognitive change. Am. J. Clin. Nutr. 82, 508-514. (Pubitemid 43073356)
57. Dhitavat, S., Rivera, E., and Shea, T.B. (2001) Differential efficacy of lipophilic and cytosolic antioxidants on generation of reactive oxygen species by amyloid-beta. J. Alzeimers Dis. 3, 525-529. (Pubitemid 34003204)
58. Liu, H., Wang, H., Shenvi, S., Hagen, T.M., and Liu, R.M. (2004) Glutathione metabolism during aging and in Alzheimer disease. Ann. N. Y. Acad. Sci. 1019, 346-349. (Pubitemid 38951332)
59. Lovell, M.A., Xie, C., and Markesbery, W.R. (1998) Decreased glutathione transferase activity in brain and ventricular fluid in Alzheimer's disease. Neurology 51, 1562-1566. (Pubitemid 28565232)
60. Pinhel, M.A., Nakazone, M.A., Cação, J.C., Piteri, R.C., Dantas, R.T., Godoy, M.F., Godoy, M.R., Tognola, W.A., Conforti-Froes, N.D., and Souza, D. (2008) Glutathione S-transferase variants increase susceptibility for late-onset Alzheimer's disease: association study and relationship with apolipoprotein E epsilon4 allele. Clin. Chem. Lab. Med. 46, 439-445.
61. Bernardini, S., Bellincampi, L., Ballerini, S., Federici, G., Iori, R., Trequattrini, A., Ciappi, F., Baldinetti, F., Bossù, P., Caltagirone, C., and Spalletta, G. (2005) Glutathione S-transferase P1 *C allelic variant increases susceptibility for late-onset Alzheimer disease: association study and relationship with apolipoprotein E epsilon4 allele. Clin. Chem. 51, 944-951. (Pubitemid 40740873)
62. Adair, J.C., Knoefel, J.E., and Morgan, N. (2001) Controlled trial of N-acetylcysteine for patients with probable Alzheimer's disease. Neurology 57, 1515-1517. (Pubitemid 32995744)
63. Del Parigi, A., Panza, F., Capurso, C., and Solfrizzi, V. (2006) Nutritional factors, cognitive decline, and dementia. Brain Res. Bull. 69, 1-19. (Pubitemid 43185339)
64. St George-Hyslop, P.H. (2000) Genetic factors in the genesis of Alzheimer's disease. Ann. N. Y. Acad. Sci. 924, 1-7.
65. Tchantchou, F., Graves, M., Ortiz, D., and Shea, T.B. (2006) S-adenosyl methionine: a connection between nutritional and genetic risk factors in Alzheimer's disease. J. Nutr. Health Aging 10, 541-544. (Pubitemid 46119580)
66. Connelly, P.J., Prentice, N.P., Cousland, G., and Bonham, J. (2008) A randomised double-blind placebo-controlled trial of folic acid supplementation of cholinesterase inhibitors in Alzheimer's disease. Int. J. Geriatr. Psychiatry 23, 155-160. (Pubitemid 351308495)
67. Kennedy, B.P., Bottiglieri, T., Arning, E., Ziegler, M.G., Hansen, L.A., and Masliah, E. (2004) Elevated Sadenosylhomocysteine in Alzheimer brain: influence on methyltransferases and cognitive function. J. Neural Transm. 111, 547-567. (Pubitemid 38478922)
68. Tchantchou, F., Graves, M., Ashline, D., Morin, A., Pimenta, A., Ortiz, D., Rogers, E., and Shea, T.B. (2004) Increased transcription and activity of glutathione synthase in response to deficiencies in folate, vitamin E and apolipoprotein E. J. Neurosci. Res. 75, 508-515. (Pubitemid 38160712)
69. Fuso, A., Seminara, L., Cavallaro, R.A., D'Anselmi, F., and Scarpa, S. (2005) S-adenosylmethionine/homocysteine cycle alterations modify DNA methylation status with consequent deregulation of PS1 and BACE and beta-amyloid production. Mol. Cell. Neurosci. 28, 195-204. (Pubitemid 39656023)
70. Scarpa, S., Fuso, A., D'Anselmi, F., and Cavallaio, R.A. (2003) Presenilin 1 gene silencing by S-adenosylmethionine: a treatment for Alzheimer disease? FEBS Lett. 541, 145-148. (Pubitemid 36428933)
71. Mischoulon, D. and Fava, M. (2002) Role of S-adenosyl-L-methionine in the treatment of depression: a review of the evidence. Am. J. Clin. Nutr. 76, 1158S-1161S. (Pubitemid 35244695)
72. Morozova, N., Khrapko, K., Panee, J., Liu, W., Harney, J.W., and Berry, M.J. (2007) Glutathione depletion in hippocampal cells increases levels of H and L ferritin and glutathione S-transferase mRNAs. Genes Cells 12, 561-567. (Pubitemid 46824954)
73. Lovell, M.A., Ehmann, W.D., Butler, S.M., and Markesbery, W.R. (1995) Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease. Neurology 45, 1594-1601.
74. Chan, A. and Shea, T.B. (2007) Effects of dietary supplementation with N-acetyl cysteine, acetyl-L-carnitine and Sadenosyl methionine on cognitive performance and aggression in normal mice and mice expressing human ApoE4. Neuromolecular Med. 9, 264-269.
75. Selley, M.L. (2007) A metabolic link between S-adenosylhomocysteine and polyunsaturated fatty acid metabolism in Alzheimer's disease. Neurobiol. Aging 28, 1834-1839. (Pubitemid 47542535)
76. Panza, F., Capurso, C., D'Introno, A., Colacicco, A.M., Capurso, A., and Solfrizzi, V. (2008) Sadenosylhomocysteine and polyunsaturated fatty acid metabolism in predementia syndromes and Alzheimer's disease. Neurobiol. Aging 29, 478-480. (Pubitemid 351215581)
77. Watkins, S.M., Zhu, X., and Zeisel, S.H. (2003) Phosphatidylethanolamine- N-methyltransferase activity and dietary choline regulate liver-plasma lipid flux and essential fatty acid metabolism in mice. J. Nutr. 133, 3386-3391. (Pubitemid 37409463)
78. Solfrizzi, V., D'Introno, A., Colacicco, A.M., Capurso, C., Todarello, O., Pellicani, V., Capurso, S.A., Pietrarossa, G., Santamato, V., Capurso, A., and Panza, F. (2006) Circulating biomarkers of cognitive decline and dementia. Clin. Chim. Acta 364, 91-112. (Pubitemid 43120631)
79. Selhub, J., Bagley, L.C., Miller, J., and Rosenberg, I.H. (2000) B vitamins, homocysteine, and neurocognitive function in the elderly. Am. J. Clin. Nutr. 71, 614S-620S. (Pubitemid 30061246)
80. Fassbender, K., Mielke, O., Bertsch, T., Nafe, B., Froschen, S., and Hennerici, M. (1999) Homocysteine in cerebral macroangiography and microangiopathy. Lancet 353, 1586-1587.
81. Lokk, J. (2003) News and views on folate and elderly persons. J. Gerontol. A Biol. Sci. Med. Sci. 58, 354-361.
82. Chan, A., Paskavitz, J., Remington, R., Rasmussen, S., and Shea, T.B. (2008-2009) Efficacy of a vitamin/nutriceutical formulation for early-stage Alzheimer's disease: a 1-year, open-label pilot study with an 16-month caregiver extension. Am. J. Alzheimers Dis. Other Demen. 23, 571-585.
83. Remington, R., Chan, A., Paskavitz, J., and Shea, T.B. (2009) Efficacy of a vitamin/nutriceutical formulation for moderate-stage to later-stage Alzheimer's disease: a placebo-controlled pilot study. Am. J. Alzheimers Dis. Other Demen. 24, 27-33.
84. Erkinjuntti, T., Kurz, A., Gauthier, S., Bullock, R., Lilienfeld, S., and Damaraju, C.V. (2002) Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial. Lancet 359, 1283-1290. (Pubitemid 34310633)
85. Feldman, H., Gauthier, S., Hecker, J., Vellas, B., Subbiah, P., and Whalen, E. (2001) A 24-week, randomized, doubleblind study of donepezil in moderate to severe Alzheimer's disease. Neurology 57, 613-620. (Pubitemid 32782987)
86. Aisen, P.S., Schafer, K.A., Grundman, M., Pfeiffer, E., Sano, M., Davis, K.L., Farlow, M.R., Jin, S., Thomas, R.G., Thal, L.J.; Alzheimer's Disease Cooperative Study (2003) Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial. JAMA 289, 2819-2826.
87. Petot, G.J. and Friedland, R.P. (2004) Lipids, diet and Alzheimer disease: an extended summary. J. Neurol. Sci. 226, 31-33. (Pubitemid 39505401)
88. Smith, M.A., Petot, G.J., and Perry, G. (1999) Diet and oxidative stress: a novel synthesis of epidemiological data on Alzheimer's disease. J. Alzheimers Dis. 1, 203-206. (Pubitemid 30829139)
89. Solfrizzi, V., Colacicco, A.M., D'Introno, A., Capurso, C., Del Parigi, A., Capurso, S.A., Argentieri, G., Capurso, A., and Panza, F. (2006) Dietary fatty acids intakes and rate of mild cognitive impairment. The Italian Longitudinal Study on Aging. Exp. Gerontol. 41, 619-627. (Pubitemid 43867225)
90. Conquer, J.A., Tierney, M.C., Zecevic, J., Bettger, W.J., and Fisher, R.H., (2000) Fatty acid analysis of blood plasma of patients with Alzheimer's disease, other types of dementia, and cognitive impairment. Lipids 35, 1305-1312. (Pubitemid 32064179)
91. Tully, A.M., Roche, H.M., Doyle, R., Fallon, C., Bruce, I., Lawlor, B., Coakley, D., and Gibney, M.J. (2003) Low serum cholesteryl ester-docosahexaenoic acid levels in Alzheimer's disease: a case-control study. Br. J. Nutr. 89, 483-489. (Pubitemid 36582118)
92. Soderberg, M., Edlund, C., Kristensson, K., and Dallner, G. (1991) Fatty acid composition of brain phospholipids in aging and in Alzheimer's disease. Lipids 26, 421-425.
93. Kalmijn, S., Launer, L.J., Ott, A., Witteman, J.C., Hofman, A., and Breteler, M.M. (1997) Dietary fat intake and the risk of incident dementia in the Rotterdam Study. Ann. Neurol. 42, 776-782. (Pubitemid 27481550)
94. Yehuda, S., Rabinovtz, S., Carasso, R.L., and Mostofsky, D.I. (1996) Essential fatty acids preparation (SR-3) improves Alzheimer's patients quality of life. Int. J. Neurosci. 87, 141-149. (Pubitemid 27111507)
95. Terano, T., Fujishiro, S., Ban, T., Yamamoto, K., Tanaka, T., Noguchi, Y., Tamura, Y., Yazawa, K., and Hirayama, T. (1999) Docosahexaenoic acid supplementation improves the moderately severe dementia from thrombotic cerebrovascular diseases. Lipids 34(Suppl.), S345-S346. (Pubitemid 29323242)
96. Freund-Levi, Y., Eriksdotter-Jönhagen, M., Cederholm, T., Basun, H., Faxén-Irving, G., Garlind, A., Vedin, I., Vessby, B., Wahlund, L.O., and Palmblad, J. (2006) ω-3 Fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD Study: a randomized double-blind trial. Arch. Neurol. 63, 1402-1408. (Pubitemid 44547551)
97. Freund-Levi, Y., Basun, H., Cederholm, T., Faxén-Irving, G., Garlind, A., Grut, M., Vedin, I., Palmblad, J., Wahlund, L.O., and Eriksdotter-Jönhagen, M. (2008) Omega-3 supplementation in mild to moderate Alzheimer's disease: effects on neuropsychiatric symptoms. Int. J. Geriatr. Psychiatry 23, 161-169. (Pubitemid 351308496)
98. Faxén Irving, G., Freund-Levi, Y., Eriksdotter-Jönhagen, M., Basun, H., Brismar, K., Hjorth, E., Palmblad, J., Vessby, B., Vedin, I., Wahlund, L.O., and Cederholm, T. (2009) Omega-3 fatty acid supplementation effects on weight and appetite in patients with Alzheimer's disease: The Omega-3 Alzheimer's Disease Study. J. Am. Geriatr. Soc. 57, 11-17.
99. Vedin, I., Cederholm, T., Freund Levi, Y., Basun, H., Garlind, A., Faxén Irving, G., Jönhagen, M.E., Vessby, B., Wahlund, L.O., and Palmblad, J. (2008) Effects of docosahexaenoic acid-rich n-3 fatty acid supplementation on cytokine release from blood mononuclear leukocytes: the OmegAD study. Am. J. Clin. Nutr. 87, 1616-1622. (Pubitemid 351872622)
100. Ray, S., Britschgi, M., Herbert, C., Takeda-Uchimura, Y., Boxer, A., Blennow, K., Friedman, L.F., Galasko, D.R., Jutel, M., Karydas, A., Kaye, J.A., Leszek, J., Miller, B.L., Minthon, L., Quinn, J.F., Rabinovici, G.D., Robinson, W.H., Sabbagh, M.N., So, Y.T., Sparks, D.L., Tabaton, M., Tinklenberg, J., Yesavage, J.A., Tibshirani, R., and Wyss-Coray, T. (2007) Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins. Nat. Med. 13, 1359-1362.
101. Kotani, S., Sakaguchi, E., Warashina, S., Matsukawa, N., Ishikura, Y., Kiso, Y., Sakakibara, M., Yoshimoto, T., Guo, J., and Yamashima, T. (2006) Dietary supplementation of arachidonic and docosahexaenoic acids improves cognitive dysfunction. Neurosci. Res. 56, 159-164. (Pubitemid 44374788)
102. Chiu, C.C., Su, K.P., Cheng, T.C., Liu, H.C., Chang, C.J., Dewey, M.E., Stewart, R., and Huang, S.Y. (2008) The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: a preliminary randomized double-blind placebo-controlled study. Prog. Neuropsychopharmacol. Biol. Psychiatry 32, 1538-1544.
103. Richardson, A.J., Allen, S.J., Hajnal, J.V., Cox, I.J., Easton, T., and Puri, B.K. (2001) Associations between central and peripheral measures of phospholipids breakdown revealed by cerebral 31-phosophorus magnetic resonance spectroscopy and fatty acid composition of erythrocyte membranes. Prog. Neuropsychopharmacol. Biol. Psychiatry 25, 1513-1521. (Pubitemid 33042694)
104. Kruman, I.I., Culmsee, C., Chan, S.L., Kruman, Y., Guo, Z., Penix, L., and Mattson, M.P. (2000) Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity. J. Neurosci.. 20, 6920-6926. (Pubitemid 30708018)
105. Tsai, M.Y., Welge, B.G., Hanson, N.Q., Bignell, M.K., Vessey, J., Schwichtenberg, K., Yang, F., Bullemer, F.E., Rasmussen, R., and Graham, K.J. (1999) Genetic causes of mild hyperhomocysteinemia in patients with premature occlusive coronary artery diseases. Atherosclerosis 143, 163-170. (Pubitemid 29138714)
106. Beyer, K., Lao, J.I., Latorre, P., and Ariza, A. (2005) Age at onset: an essential variable for the definition of genetic risk factors for sporadic Alzheimer's disease. Ann. N. Y. Acad. Sci. 1057, 260-278. (Pubitemid 43211640)
107. Lim, W.S., Gammack, J.K., Van Niekerk, J.K., and Dangour, A. (2006) Omega 3 fatty acid for the prevention of dementia. Cochrane Database Syst. Rev. CD005379.
108. van de Rest, O., Geleijnse, J.M., Kok, F.J., van Staveren, W.A., Dullemeijer, C., Olderikkert, M.G., Beekman, A.T., and de Groot, C.P. (2008) Effect of fish oil on cognitive performance in older subjects: a randomized, controlled trial. Neurology 71, 430-438.
109. Dangour, A.D., Clemens, F., Elbourne, D., Fasey, N., Fletcher, A.E., Hardy, P., Holder, G.E., Huppert, F.A., Knight, R., Letley, L., Richards, M., Truesdale, A., Vickers, M., and Uauy, R. (2006) A randomised controlled trial investigating the effect of n-3 long-chain polyunsaturated fatty acid supplementation on cognitive and retinal function in cognitively healthy older people: the Older People And n-3 Long-chain polyunsaturated fatty acids (OPAL) study protocol [ISRCTN72331636]. Nutr. J. 5, 20.
110. Dangour, A.D., Allen, E., Elbourne, D., Fletcher, A., Richards, M., and Uauy, R. (2009) Fish consumption and cognitive function among older people in the UK: baseline data from the Opal Study. J. Nutr. Health Aging 13, 198-202.
111. Solfrizzi, V., Panza, F., Torres, F., Mastroianni, F., Del Parigi, A., Venezia, A., and Capurso, A. (1999) High monounsaturated fatty acids intake protects against age-related cognitive decline. Neurology 52, 1563-1569. (Pubitemid 29220628)
112. Briante, R., Febbraio, F., and Nucci, R. (2003) Antioxidant properties of low molecular weight phenols present in the Mediterranean diet. J. Agric. Food Chem. 51, 6975-6981.
113. Joseph, J.A., Shukitt-Hale, B., Denisova, N.A., Bielinski, D., Martin, A., McEwen, J.J., and Bickford, P.C. (1999) Reversals of age-related declines in neuronal signal transduction; cognitive and motor behavioral deficits with blueberry; spinach or strawberry dietary supplementation. J. Neurosci. 19, 8114-8121. (Pubitemid 30225807)
114. Solfrizzi, V., Panza, F., and Capurso, A. (2003) The role of diet in cognitive decline. J. Neural Transm. 110, 95-110.
115. Favrelere, S., Stadelmann-Ingrand, S., Huguet, F., De Javel, D., Piriou, A., Tallineau, C., and Durand, G. (2000) Agerelated changes in ethanolamine glycerophospholipid fatty acid levels in rat frontal cortex and hippocampus. Neurobiol. Aging 21, 653-660. (Pubitemid 30759076)
116. Delion, S., Chalon, S., Hearault, J., Guilloteau, D., Besnard, J.-C., and Durand, G. (1994) Chronic dietary-linolenic acid deficiency alters dopaminergic and serotoninergic neurotransmission in rats. J. Nutr. 124, 2466-2476.
117. Horrocks, L.A. and Yeo, Y.K. (1999) Health benefits of docosahexaenoic acid [DHA]. Pharmacol. Res. 40, 211-225. (Pubitemid 29435720)
118. Keli, S.O., Feskens, E.J., and Kromhout, D. (1994) Fish consumption and risk of stroke. The Zutphen Study. Stroke 25, 328-332. (Pubitemid 24047253)
119. Marchiali, R., Barzi, F., Bomba, E., Chieffo, C., Di Gregorio, D., Di Mascio, R., Franzosi, M.G., Geraci, E., Levantesi, G., Maggioni, A.P., Mantini, L., Marfisi, R.M., Mastrogiuseppe, G., Mininni, N., Nicolosi, G.L., Santini, M., Schweiger, C., Tavazzi, L., Tognoni, G., Tucci, C., Valagussa, F., GISSI-Prevenzione Investigators (2002) Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardio [GISSI]-Prevenzione. Circulation 105, 1897-1903.
120. Crawford, M.A., Bloom, M., Broadhurst, C.L., Schmidt, W.F., Cunnane, S.C., Galli, C., Gehbremeskel, K., Linseisen, F., Lloyd-Smith, J., and Parkington, J. (1999) Evidence for the unique function of docosahexaenoic acid during the evolution of the modern hominid brain. Lipids 34(Suppl.), S39-S47. (Pubitemid 29323131)
121. Reaven, P.D., Grasse, B.J., and Tribble, D.L. (1994) Effects of linoleate-enriched and oleate-enriched diets in combination with alpha-tocopherol on the susceptibility of LDL and LDL subfractions to oxidative modification in humans. Arterioscler. Thromb. 14, 557-566. (Pubitemid 24116926)
122. Blankenhorn, D.H., Johnson, R.L., Mack, W.J., el Zein, H.A., and Vailas, L.I. (1990) The influence of diet on the appearance of new lesions in human coronary arteries. JAMA 263, 1646-1652.
123. de Lorgeril, M., Salen, P., Martin, J.L., Monjaud, I., Boucher, P., and Mamelle, N. (1998) Mediterranean dietary pattern in a randomized trial: prolonged survival and possible reduced cancer rate. Arch. Intern. Med. 158, 1181-1187. (Pubitemid 28252481)
124. Solfrizzi, V., Capurso, C., D'Introno, A., Colacicco, A.M., Santamato, A., Ranieri, M., Fiore, P., Capurso, A., and Panza, F. (2008) Lifestyle-related factors in predementia and dementia syndromes. Export. Rev. Neurother. 8, 133-158.
125. Ambring, A., Friberg, P., Axelsen, M., Laffrenzen, M., Taskinen, M.R., Basu, S., and Johansson, M. (2004) Effects of a Mediterranean-inspired diet on blood lipids; vascular function and oxidative stress in healthy subjects. Clin. Sci.106, 519-525. (Pubitemid 38639556)
126. Panza, F., Frisardi, V., Capurso, C., D'Introno, A., Colacicco, A.M., Vendemiale, G., Capurso, A., and Solfrizzi, V. (2009) Possible role of s-adenosylmethionine, s-adenosylhomocysteine, and polyunsaturated fatty acids in predementia syndromes and Alzheimer's disease. J. Alzheimers Dis. 16, 467-470.